Prenetics Global (PRE) Common Equity (2021 - 2026)

Prenetics Global (PRE) has reported Common Equity for 6 consecutive years, with $121.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Common Equity fell 24.88% year-over-year to $121.0 million; the TTM figure through Mar 2026 stood at $121.0 million (down 24.88% YoY), while the FY2025 annual figure was $156.4 million, down 8.23% from the prior year.
• Common Equity declined to $121.0 million in Q1 2026 per PRE's latest filing, from $156.4 million in the prior quarter.
• Across five years, Common Equity topped out at $237.1 million in Q4 2022 and bottomed at -$424.9 million in Q1 2022.
• Historically, Common Equity has averaged $154.3 million across 5 years, with a median of $191.0 million in 2024.
• Annual changes were most pronounced in 2022 — Common Equity soared 159.15% — and 2026, when it decreased 24.88%.
• Prenetics Global's Common Equity stood at $237.1 million in 2022, then dropped by 12.95% to $206.4 million in 2023, then dropped by 17.43% to $170.4 million in 2024, then decreased by 8.23% to $156.4 million in 2025, then decreased by 22.6% to $121.0 million in 2026.
• Business Quant data shows PRE's Common Equity at $121.0 million in Q1 2026, $156.4 million in Q4 2025, and $161.2 million in Q3 2025.